AI assistant
BTC HEALTH LTD — Net Asset Value 2012
Dec 2, 2012
64575_rns_2012-12-02_89c5babf-c41a-4a08-bdd3-2c91be966d7c.pdf
Net Asset Value
Open in viewerOpens in your device viewer
==> picture [126 x 94] intentionally omitted <==
03 December 2012: Net Tangible Asset (NTA) Backing – November 2012
| 30 November 2012 | 30 November 2012 | Cost Price Board Valuation1 |
Cost Price Board Valuation1 |
Cost Price Board Valuation1 |
|---|---|---|---|---|
| Company | ASX Code | Cost Price Cents per BTC share |
Current Value Cents per BTC share* |
|
| UNLISTED SECURITIES Sensear TOTAL UNLISTED SECURITIES Cash |
3,116,761 $ 4.18c |
2,737,966 $ 3.67c |
||
| 3,116,761 $ 4.18c |
2,737,966 $ 3.67c |
|||
| 565,736 $ 0.76c |
565,736 $ 0.76c |
|||
| Tax Provision | - $ 0.00c |
- $ 0.00c |
||
| TOTAL | 3,682,497 $ 4.94c |
3,303,703 $ 4.43c |
1 Board Valuation as defined by BioTech Capital's Investment policy including provision for tax
BioTech Capital issued capital: Ordinary Shares 74,554,108
Commentary - activities during the last month
Proceeds of $231,143.81 from the voluntary wind-up of Biocomm Services Pty Ltd were received in November 2012.
This leaves one remaining investment being Sensear Pty Ltd. The Board is actively pursuing an appropriate exit mechanism for this stake. In the interim, the Board has resolved to write down the carrying value of its holding to reflect the illiquidity discount as well as reflect certain rights attaching to incoming Sensear investors.
Valuations
The “Board Valuation” column is based upon the investment policy of the Board and is broadly in line with industry standard practices.
About BioTech Capital Ltd
BioTech Capital Ltd (“BTC”) is a listed investment fund currently conducting an orderly wind-down of its holdings pursuant to a change in investment activity approved by shareholders in 2010. As a registered Pooled Development Fund (PDF), investors are generally exempt from tax on capital gains and income. BTC is listed on the Australian Stock Exchange (Code: BTC). Additional information can be found at www.biotechcapital.com.au
Contact Information
Alastair Davidson Chairman, Biotech Capital Ltd Ph: +61 413 433 640 E-mail: [email protected]
Biotech Capital Limited ABN 45 091 979 172 www.biotechcapital.com.au
1 Edmondson Crescent Karrinyup WA 6018 Australia
T+61 413 056 328 F+61 8 6210 1567